Origo Biopharma - Ownership and Business Overview

Life ScienceCompany

Origo Biopharma Ownership

Who owns Origo Biopharma?

Origo Biopharma is owned by AgomAb Therapeutics NV. It was acquired on October 28, 2021.

Origo Biopharma Business Overview

Where is Origo Biopharma headquartered?

Origo Biopharma is headquartered in Fonte Diaz, Spain.

What sector is Origo Biopharma in?

Origo Biopharma is a life science company.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 387 acquisitions of life science companies in 2021, including 43 acquisitions by private equity firms, and 344 by strategics.

Origo Biopharma

Origo Biopharma S.L.

Parque Empresarial de Touro, Parcelas 26-27,
Fonte Diaz, 15822
Spain,
www.origobiopharma.com

Origo Biopharma is a clinical stage biotechnology company developing organ-restricted small molecule drug candidates targeting the transforming growth factor beta (TGF-β) pathway for the treatment of fibrosis-related disorders. Origo Biopharma is based in Fonte Diaz, Spain.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 201,888
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Origo Biopharma

Life Science Companies , Spain Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Spain Companies

Largest Spain Companies , Acquisitive Spain Companies , Recently Acquired Spain Companies , Recently Sold Spain Companies , Private Spain Companies , Public Spain Companies , Acquired Spain Companies , PE Backed Spain Companies
Mergr

Product

Company

Legal